Oklahoma Children's Hospital at OU Health formerly known as The Children's Hospital of Oklahoma and The Children's Hospital at OU Medicine is a nationally ranked, freestanding acute care women's and children's hospital in Oklahoma City, Oklahoma. It is affiliated with the University of Oklahoma College of Medicine. The hospital features all private rooms that consist of 246 pediatric beds. The hospital provides comprehensive pediatric specialties and subspecialties to infants, children, teens, and young adults aged 0–21 throughout the region. The hospital also sometimes treats adults that require pediatric care. The hospital has a rooftop helipad and is an ACS verified level I pediatric trauma center, the only one in Oklahoma. The hospital features a regional pediatric intensive-care unit and an American Academy of Pediatrics verified level IV neonatal intensive care unit.
BACKGROUND:Food insecurity (FI) has documented negative health impacts on children, with a higher prevalence in children with kidney disease. The prevalence and consequences of FI in pediatric kidney transplant recipients are unknown. METHODS:In this study, we screened and assessed pediatric kidney transplant recipients for FI using the Hunger Vital Sign and analyzed the impact of FI on pediatric kidney transplant outcomes. RESULTS:Of the 118 pediatric kidney transplant recipients screened, 23 (19.5%) were identified as FI. Food-secure and food-insecure recipients were not significantly different in age or gender, but there was significantly more FI in recipients of Hispanic ethnicity (56% vs. 30%) and with public insurance (83% vs. 52%). Markers of nutrient stores and transplant outcomes were not significantly different in recipients with FI. CONCLUSION:Our study highlights the feasibility and importance of screening pediatric kidney transplant recipients for FI with the Hunger Vital. The observed link of FI with demographic characteristics such as Hispanic ethnicity and having public insurance offers potential targets for intervention. Larger studies assessing FI and outcomes in pediatric transplant recipients are critical for focused interventions and policy development.
BACKGROUND:Blunt cerebrovascular injury (BCVI) is rare but significant among injured children. Current BCVI screening criteria lack adequate diagnostic accuracy for pediatrics. This preplanned secondary analysis identified common risk factors for BCVI among a multicenter cohort of pediatric trauma centers within the ATOMAC+ Pediatric Trauma Research Network (APTRN) and derived a new set of screening criteria. METHODS:A prospective, multi-institutional observational study of children <15 years old who sustained blunt trauma to the head, face, or neck (AIS > 0) who presented at one of six level I pediatric trauma centers over a 3-year period was conducted. Patients were prospectively screened using the Memphis criteria to determine need for diagnostic imaging. Additional physical and diagnostic examination findings, risk factors, and screening data were also collected for analysis. RESULTS:A total of 2,283 patients were enrolled at the six trauma centers and 25 (1.09%) were diagnosed with a BCVI. Patients without two-week follow up were excluded from analysis, leaving 1327 patients for analysis. Many injuries predicted BCVI on univariate analysis in the study population ( p < 0.0001). When examined with a multivariable logistic regression model, temporal fractures, sphenoid fractures, orbital roof fractures, fractures of C1-4, and/or ligamentous injuries of the cervical spine predicted BCVI in pediatric trauma patients with blunt head, face, or neck injuries. These criteria are used to define a set of screening criteria that are specific to pediatrics and practical to implement. CONCLUSION:The A+ criteria for BCVI screening among pediatric trauma patients suggests a high sensitivity and specificity by including significant injuries and symptoms. These predictors of BCVI may be used to identify pediatric blunt trauma patients at high risk for BCVI while limiting radiation exposure to children. LEVEL OF EVIDENCE:Diagnostic Tests or Criteria; Level III.